WST
West Pharmaceutical Services, Inc.
Stock
$364.98−0.03 (−0.01%)Close Oct 2, 2026
- Operating income, 2025
- $585M
- YoY, 2025
- +2.6%
- 5-year CAGR
- +7.5%
- 10-year CAGR
- +16.4%
Operating income
Operating income by fiscal year
| Period | Operating income | YoY |
|---|---|---|
| 2025 | $585M | +2.6% |
| 2024 | $570M | −15.7% |
| 2023 | $676M | −7.9% |
| 2022 | $734M | −2.4% |
| 2021 | $752M | +84.9% |
| 2020 | $407M | +37.2% |
| 2019 | $297M | +23.4% |
| 2018 | $240M | +6.4% |
| 2017 | $226M | +15.7% |
| 2016 | $195M | +51.8% |
| 2015 | $129M | −29.3% |
| 2014 | $182M | +12.1% |
| 2013 | $162M | +20.2% |
| 2012 | $135M | +23.3% |
| 2011 | $110M | +20.8% |
| 2010 | $91M | −7.0% |
| 2009 | $98M | −21.4% |
| 2008 | $124M | — |